House Subcommittee Holds Hearing on HIPAA Privacy Rule

March 22, 2001-- The House Energy and Commerce Health Subcommittee held a hearing today entitled, "Assessing HIPAA: How Federal Medical Record Privacy Regulations Can Be Improved."

The hearing held on March 22, 2001 was intended to focus on the unintended consequences of the Health Insurance Portability and Accountability Act’s (HIPAA) medical record privacy regulations.

The following witnesses appeared at Thursday’s hearing:

Dr. John Melski, Medical Director of Informatics, Marshfield Clinic - Marshfield, WI
Testimony

John D. Clough, MD, Director of Health Affairs, Cleveland Clinic Foundation - Cleveland, OH
Testimony

Mr. Bob Heird, Senior Vice President, Anthem BlueCross BlueShield - Indianapolis, IN
Testimony

Mr. Carlos R. Ortiz, Director of Government Affairs, CVS Pharmacy - Woonsocket, RI
Testimony

Ms. Janlori Goldman, Director, Health Privacy Project, Institute for Health Care Research and Policy, Georgetown University - Washington, DC
Testimony

Dr. Paul Appelbaum, A.F. Zeleznik Professor of Psychiatry, Chairman, Department of Psychiatry, University of Massachusetts Medical School - Worcester, MA
Testimony

Ms. Mary E. Foley, President, American Nurses Association - Washington, DC
Testimony